Edition:
United States

Insider Trading: CTi Biopharma Corp (CTIC.PH)

CTIC.PH on Philadelphia Stock Exchange

0.35USD
11:08am EDT
Change (% chg)

$-0.00 (-0.60%)
Prev Close
$0.35
Open
$0.35
Day's High
$0.35
Day's Low
$0.35
Volume
2,600
Avg. Vol
4,835
52-wk High
$1.93
52-wk Low
$0.26

All Insider Trades
Trading Date Name Title Type Shares Traded Price
29 Jun 2016

Seeley (Bruce J)

Officer Buy 5,000 $0.29
23 Jun 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.37
26 May 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.45
28 Apr 2016

Nudelman (Phillip M)

Director Buy 79,618 $0.00
28 Apr 2016

Mundinger (Mary Oneil)

Director Buy 63,695 $0.00
28 Apr 2016

Tuckson (Reed Vaughn M.D.)

Director Buy 63,695 $0.00
28 Apr 2016

Love (Richard L)

Director Buy 63,695 $0.00
28 Apr 2016

Telling (Frederick W)

Director Buy 63,695 $0.00
28 Apr 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.52
27 Mar 2016

Bianco (James A)

Chief Executive Officer Sell 10,000 $0.49
20 Mar 2016

Bianco (James A)

Chief Executive Officer Sell 318,169 $0.55
20 Mar 2016

Plunkett (Matthew J)

Officer Sell 63,874 $0.55
20 Mar 2016

Bianco (Louis A)

Officer Sell 46,556 $0.55
20 Mar 2016

Singer (Jack W)

Officer and Director Sell 45,935 $0.55
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 900 $0.60
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,300 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 400 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,220 $0.60
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 1,100 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 500 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 844 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 700 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 700 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 636 $0.59
3 Mar 2016

Plunkett (Matthew J)

Officer Sell 200 $0.59

Institutional Holders

% Shares Owned: 38.95%
# of Holders: 107
Total Shares Held: 110,156,643
3 Mo. Net Change: -169,413
# New Positions: 0
# Closed Positions: 6
# Increased Positions: 0
# Reduced Positions: 6
# Net Buyers: -6

Officers & Directors

Name Age Since Current Position

Phillip Nudelman

79 2005 Independent Chairman of the Board

James Bianco

58 2012 President, Chief Executive Officer, Director

Louis Bianco

62 2013 Executive Vice President, Finance and Administration, and Chief Governance Officer

Jack Singer

72 2013 Interim Chief Medical Officer, Executive Vice President, Global Medical Affairs and Translational Medicine, and Chief Compliance Officer.

Matthew Plunkett

43 2012 Executive Vice President, Corporate Development

Bruce Seeley

51 2015 Executive Vice President and Chief Commercial Officer

Nancy Boman

Senior Vice President of Clinical Development and Regulatory Affairs

Monique Greer

48 Senior Vice President of Corporate Communications and Investor Relations

Matthew Perry

2016 Director

Richard Love

72 2007 Independent Director

Frederick Telling

63 2006 Independent Director

Reed Tuckson

64 2011 Independent Director

Ed Bell

Director - Investor Relations